In South-Eastern Europe, and Western and Central Europe, amphetamine-type stimulants (ATS) use and health harm remain mainly linked to amphetamine and are relatively low compared to other regions.Amphetamines are the third most common stimulant drugs group in Europe after cocaine and “ecstasy”.…
Methamphetamine and other ATS remain the leading substances for which people seek drug treatment in East and South-East Asia.The number of people receiving treatment for ATS use, mainly methamphetamine, has remained stable or declined in the majority of reporting countries – with the exception of…
Cannabis use in Europe stabilizes after long-term growth.Cannabis remains the most widely used drug in Europe, with an estimated 31 million users in 2024 (10 million women and 21 million men).In the majority of countries with available data, use has stabilized in recent years following long-term…
The synthetic drugs market in the Near and Middle East remains dynamic, following disruptions in the supply of “captagon”.The Near and Middle East accounted for 77 per cent of global “captagon” seizures in 2020–2024, with production mainly in the Syrian Arab Republic and Lebanon and trafficking…
Cocaine use continues to increase in Western and Central Europe as well as South-Eastern Europe, according to several indicators of use and harm.In 2024, demand-side and supply-side domestic market indicators showed diverging trends in Western and Central Europe, suggesting localized disruptions…
Cocaine is the second most used drug in Europe, after cannabis. However, per capita consumption of the substance tends to be lower than in the Americas.Annual use of cocaine is relatively high in Western and Central Europe (the subregion with the third highest average prevalence in the world) and…
The “ecstasy” market remains concentrated in Europe (mainly Western and Central Europe)The use of “ecstasy” is relatively high in Western and Central Europe with nearly 4 million of people estimated to have used the substance in the past year in 2024. In contrast, the estimated number of users was…
Asia has increasingly become a transit and destination region for cocaine trafficking and use over the past decade, although the growth in indicators of availability and use is moderate.Cocaine seizures in Asia increased more than sixfold between 2015 and 2024. Additionally, the number of seizures…
Seizures of methamphetamine in Asia continue to rise, even as the reported number of dismantled methamphetamine laboratories declines.Methamphetamine seizures in Asia reached a record high in 2024, while the number of dismantled (and reported) methamphetamine laboratories declined to its lowest…
Seizures of methamphetamine continued rising in South-East Asia while declining in East Asia.The largest quantities of methamphetamine worldwide were seized in East and South-East Asia, accounting for 48 per cent of the world’s total in 2024.Seizures of methamphetamine have been declining over the…
Methamphetamine seizures now dominate overall seizures of amphetamine-type stimulants (ATS) in the Near and Middle East/South-West Asia.Until 2022, ATS seizures in the subregion were dominated by amphetamine – notably “captagon” – but methamphetamine seizures have continued to rise since while…
In East and South-East Asia, limited regular data collection makes it difficult to assess long-term trends in opioid use. However, data on people registered for drug use and people in drug treatment indicate a decline in opioid (mainly heroin) use over the past 10 to 15 years.In most of East and…
